Timothy Hoey
Chief Tech/Sci/R&D Officer bei TENAYA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Dr. Timothy Hoey is a Chief Scientific Officer at Tenaya Therapeutics, Inc. Dr. Hoey was previously employed as a Co-Chief Scientific Officer & SVP-Cancer Biology by OncoMed Pharmaceuticals, Inc., a Director-Biology Department by Amgen, Inc., and a Director-Biology Department by Tularik, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from The Trustees of Columbia University in The City of New York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.03.2024 | 245 346 ( 0,31% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Timothy Hoey
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.08.2017 |
Ehemalige bekannte Positionen von Timothy Hoey
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01.01.2017 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director/Board Member | 14.12.2011 |
Ausbildung von Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
